Company profile ALZN

Alzamend Neuro Inc
alzamend neuro is a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of alzheimer’s disease, bipolar disorder, major depressive disorder (“mdd”) and post-traumatic stress disorder (“ptsd”). our mission is to rapidly develop and market safe and effective treatments to bring aid to the 43+ million americans suffering from t...hese debilitating diseases. our current pipeline consists of two novel therapeutic drug candidates, al001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and alzn002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient’s immunological system to combat alzheimer’s. Show More
Quarter analysis & expected interestLast update: February 08 2024 14:32:01.

After 39 days of this quarter the interest is at 40.0. Based on that we can calculate that during remaining 52 days it will total up to 93.0.
Alzamend Neuro expected interest is significantly higher compared to same quarter last year (+272.0%) but similar to previous quarter.

YearQ1Q2Q3Q4
201978
81
3.8% QoQ
48
-40.7% QoQ
130
170.8% QoQ
2020 58
-25.6% YoY -55.4% QoQ
44
-45.7% YoY -24.1% QoQ
23
-52.1% YoY -47.7% QoQ
59
-54.6% YoY 156.5% QoQ
2021 0
-100.0% YoY -100.0% QoQ
254
477.3% YoY inf% QoQ
168
630.4% YoY -33.9% QoQ
191
223.7% YoY 13.7% QoQ
2022 270
inf% YoY 41.4% QoQ
175
-31.1% YoY -35.2% QoQ
159
-5.4% YoY -9.1% QoQ
45
-76.4% YoY -71.7% QoQ
2023 25
-90.7% YoY -44.4% QoQ
37
-78.9% YoY 48.0% QoQ
42
-73.6% YoY 13.5% QoQ
107
137.8% YoY 154.8% QoQ
2024 40
60.0% YoY -62.6% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Alzamend Neuro search interestLast update: February 08 2024 14:32:00.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 14:32:02.

The average 5 years interest of Alzamend Neuro was 7.79 per week.
The last year interest of Alzamend Neuro compared to the last 5 years has changed by -38.0%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -34.46%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Alzamend Neuro AL001 to provide analysis

Correlation between past revenue and Alzamend Neuro AL001 search interest

There is not enough data for Alzamend Neuro AL001 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Alzamend Neuro AL001 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Alzamend Neuro ALZN002 to provide analysis

Correlation between past revenue and Alzamend Neuro ALZN002 search interest

There is not enough data for Alzamend Neuro ALZN002 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Alzamend Neuro ALZN002 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Alzamend Neuro Alzheimer's treatment to provide analysis

Correlation between past revenue and Alzamend Neuro Alzheimer's treatment search interest

There is not enough data for Alzamend Neuro Alzheimer's treatment to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Alzamend Neuro Alzheimer's treatment to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Alzamend Neuro pipeline to provide analysis

Correlation between past revenue and Alzamend Neuro pipeline search interest

There is not enough data for Alzamend Neuro pipeline to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Alzamend Neuro pipeline to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Alzamend Neuro clinical trials to provide analysis

Correlation between past revenue and Alzamend Neuro clinical trials search interest

There is not enough data for Alzamend Neuro clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Alzamend Neuro clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Alzamend Neuro stock price to provide analysis

Correlation between past revenue and Alzamend Neuro stock price search interest

There is not enough data for Alzamend Neuro stock price to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Alzamend Neuro stock price to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: October 15 2023 01:29:51.

After 92 days of this quarter the interest is at 43.0. Based on that we can calculate that during remaining 0 days it will total up to 43.0.
Alzamend Neuro news expected interest is significantly higher compared to same quarter last year (+59.3%) but similar to previous quarter.

YearQ1Q2Q3Q4
2018 - - - 99
2019 73
-26.3% QoQ
144
97.3% QoQ
52
-63.9% QoQ
61
-38.4% YoY 17.3% QoQ
2020 152
108.2% YoY 149.2% QoQ
120
-16.7% YoY -21.1% QoQ
159
205.8% YoY 32.5% QoQ
174
185.2% YoY 9.4% QoQ
2021 59
-61.2% YoY -66.1% QoQ
48
-60.0% YoY -18.6% QoQ
118
-25.8% YoY 145.8% QoQ
204
17.2% YoY 72.9% QoQ
2022 23
-61.0% YoY -88.7% QoQ
132
175.0% YoY 473.9% QoQ
27
-77.1% YoY -79.5% QoQ
134
-34.3% YoY 396.3% QoQ
2023 46
100.0% YoY -65.7% QoQ
62
-53.0% YoY 34.8% QoQ
43
59.3% YoY -30.6% QoQ
0
-100.0% YoY -100.0% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Alzamend Neuro news search interestLast update: October 15 2023 01:29:49.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: October 15 2023 01:29:51.

The average 5 years interest of Alzamend Neuro news was 7.39 per week.
The last year interest of Alzamend Neuro news compared to the last 5 years has changed by -25.85%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -22.6%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Alzamend Neuro careers to provide analysis

Correlation between past revenue and Alzamend Neuro careers search interest

There is not enough data for Alzamend Neuro careers to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Alzamend Neuro careers to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Alzamend Neuro contact to provide analysis

Correlation between past revenue and Alzamend Neuro contact search interest

There is not enough data for Alzamend Neuro contact to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Alzamend Neuro contact to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for ALZN
Earnings date: 2024-03-15 After close
Company name: Alzamend Neuro Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-04-07T08:00:00-04:00

PR Newswire
Alzamend Neuro Reports Encouraging Pharmacodynamic Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study in a Trial Conducted at Massachusetts General Hospital

2026-03-26T08:00:00-04:00

PR Newswire
Alzamend Neuro Reports Positive Topline Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study; AL001 Achieves Bioequivalence and Demonstrates Superior Brain Delivery Across All Measured Brain Regions

2026-03-16T08:00:00-04:00

PR Newswire
Alzamend Neuro Initiates Phase II Clinical Trial of AL001 "Lithium in Brain" Study in Patients with Bipolar Disorder in Collaboration with Massachusetts General Hospital

2025-12-22T12:15:20Z

Analyst Upgrades
Ascendiant Capital Maintains Buy on Alzamend Neuro, Lowers Price Target to $28

2025-11-19T08:00:00-05:00

PR Newswire
Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 "Lithium in Brain" Study Conducted at Massachusetts General Hospital

2025-10-14T16:51:54-04:00

SEC
8-K Form - Current report, items 5.03 and 9.01 - Alzamend Neuro, Inc. (0001677077) (Filer)

2025-10-10T16:30:13-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Alzamend Neuro, Inc. (0001677077) (Issuer)

2025-10-09T16:30:32-04:00

SEC
8-K Form - Current report, items 3.02 and 9.01 - Alzamend Neuro, Inc. (0001677077) (Filer)

2025-10-08T06:50:55-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Alzamend Neuro, Inc. (0001677077) (Issuer)

2025-10-07T21:53:55-04:00

SEC
SCHEDULE 13D/A Form - [Amend] General Statement of Acquisition of Beneficial Ownership - Alzamend Neuro, Inc. (0001677077) (Subject)

2025-10-03T21:37:27-04:00

SEC
SCHEDULE 13D/A Form - [Amend] General Statement of Acquisition of Beneficial Ownership - Alzamend Neuro, Inc. (0001677077) (Subject)

2025-10-03T21:35:01-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Alzamend Neuro, Inc. (0001677077) (Issuer)

2025-09-30T20:51:09-04:00

SEC
SCHEDULE 13D/A Form - [Amend] General Statement of Acquisition of Beneficial Ownership - Alzamend Neuro, Inc. (0001677077) (Subject)

2025-09-30T19:15:07-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Alzamend Neuro, Inc. (0001677077) (Issuer)

2025-09-25T21:37:15-04:00

SEC
SCHEDULE 13D/A Form - [Amend] General Statement of Acquisition of Beneficial Ownership - Alzamend Neuro, Inc. (0001677077) (Subject)